Valuation: Stemcell United Limited

Market Cap 3.53M 2.47M 2.16M 1.99M 1.84M 3.47M 237M 23.77M 9.32M 116M 9.27M 9.06M 400M P/E 2024
-0.35x
P/E 2025 -0.75x
Enterprise Value 3.38M 2.36M 2.06M 1.91M 1.76M 3.32M 227M 22.74M 8.92M 111M 8.87M 8.67M 382M EV / Sales 2024
11.9x
EV / Sales 2025 5.53x
Free-Float
96.73%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 55 2023-11-20
Chief Tech/Sci/R&D Officer - 2026-05-24
Corporate Secretary - 2024-04-10
Director TitleAgeSince
Chairman - 2026-06-21
Director/Board Member - 2019-05-26
Director/Board Member 55 2023-03-29
Change 5-day change 1-year change 3-year change Capi.($)
+50.00%-.--% - - 2.47M
-1.05%+1.39%+3.15%+6.98% 50.35B
+0.55%-2.88%+382.07%+593.81% 39.32B
+0.13%-0.19%+29.79%-6.00% 34.69B
+0.86%-0.78%+21.58%+56.15% 34.08B
-1.31%-3.03%+2.51%+25.24% 26.63B
+0.13%-0.52% - - 16.49B
+1.13%-1.85%+67.36%+120.46% 15.31B
-0.72%+0.12%+14.69%+16.95% 13.8B
+1.13%-0.44%+12.34%-31.79% 12.87B
Average +5.09%-0.97%+66.69%+97.72% 27.06B
Weighted average by Cap. -0.03%-0.91%+81.09%+122.22%

Financials

2024 2025
Net sales 110K 76.84K 67.15K 62.08K 57.35K 108K 7.38M 740K 290K 3.61M 289K 282K 12.45M 352K 246K 215K 199K 184K 346K 23.65M 2.37M 931K 11.58M 925K 905K 39.88M
Net income -2.65M -1.85M -1.62M -1.5M -1.38M -2.6M -178M -17.85M -7M -87.16M -6.96M -6.81M -300M -1.49M -1.04M -908K -839K -775K -1.46M -99.78M -10.01M -3.93M -48.86M -3.9M -3.82M -168M
Net Debt 119K 83.51K 72.98K 67.46K 62.33K 117K 8.02M 804K 316K 3.93M 314K 307K 13.52M -153K -107K -93.28K -86.23K -79.67K -150K -10.25M -1.03M -403K -5.02M -401K -392K -17.29M
Logo Stemcell United Limited
BPH Global Limited is an Australia-based plant-focused biotechnology company. The Company is focused on producing foods, health and cosmetic products which deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research and development, production and commercialization of TCM products, including raw bird’s nest and processed bird’s nest products, raw seaweed and sea plants as sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients extracted from seaweed and sea plants for utilization in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. The Company’s product focus is on raw bird’s nests; higher end processed bird’s nest products; and Sea Grapes (Caulerpa Lentillifera) and seaweeds. Its subsidiaries include Hainan SCU Biotechnology Co Ltd, Foshan Gedishi Biotechnology Co Ltd, SCU Lab Pty Ltd, PT BPH Global Indonesia, Stemcell United Pte Ltd and others.
Employees
-